KMT2A and leukemia: DOT1L has additionally been implicated in oncogenesis for multiple leukemias, including mixed lineage leukemia (MLL), acute lymphoblastic leukemia (ALL), and acute myeloid leukemia (AML) (McLean et al., 2014).